The life sciences arena is buzzing with disruptive technology and innovations. As life sciences stand at the crossroads of emerging trends, heightened global competition, stringent regulatory standards and continuous cost pressures have made efficient discoveries in research and development more imperative than ever. Breakthrough developments are significantly affecting the industry nudging companies to make a fundamental shift in the development and commercialization of drugs. Organizations are embracing new technological advances and investing heavily in therapeutic innovations in biomarker testing, diagnostics and gene-cell therapies. Simultaneously, continuing the exploration on utilizing AI, machine learning and blockchain, enterprises are leveraging these technologies to augment standard models and processes ultimately driving greater operational efficiency with end-to-end visibility across the organization.
With the advent of multiple cloud solutions and mobile devices, better collaboration between the various industry stakeholders and clinical data management teams is growing at a faster pace. Organizations can bring in their data together, organize and analyze the aggregated information to uncover intelligent insights from it using AI. This way, using mobile devices, they can deliver the right information to the concerned individuals at the point of requirement. Digitization will also enable the providers to utilize technology in real-time for intelligent and smarter decision-making.
Industry players are on the move to adopt strategic, relationship-based models for functioning, which will likely stimulate data-driven clinical developments to bolster manufacturing capacities. Through an increasing deployment of cognitive automation, cloud computing and AI, companies can streamline their supply chain, manage the capacity gap and bring in personalized medicines improving their time to market. Life sciences providers are evolving to adopt a more patient-centric approach designed around building a trust factor with their partners alongside promising value-based care to their patients, which re-aligns patient incentives, and redirects it to them.
With all these challenges and evolution set in the backdrop, CIOs, CEOs and CTOs are faced with the complex task of finding the best of the providers in the industry. This edition of APAC CIO Outlook gives you an insight into the “Top 10 Life Science Tech Consulting/Services Companies 2019.” The proposed list will help you derive the what, why and how on some of the most prominent organizations in the industry.
